Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.26 USD | +0.29% | -4.65% | -29.88% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.88% | 1.44B | |
-16.75% | 11.52B | |
+40.53% | 3.27B | |
-19.90% | 2.02B | |
+14.43% | 1.01B | |
-6.11% | 719M | |
-32.00% | 418M | |
-51.12% | 339M | |
-3.18% | 284M | |
+24.60% | 240M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Insider Sell: Veracyte